The short version
9 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Guaifenesin D
Guaifenesin and Pseudoephedrine Hydrochloride · GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1 · Tablet, Extended Release · Oral · Walgreen Company
NDC 00363-9930-18 · 1 BLISTER PACK in 1 CARTON / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.2%chance of a new FDA shortage posting for guaifenesin and pseudoephedrine hydrochloride (oral solid) in the next 90 days
price up 24% YoY · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- ANDA212542
- TE code
- —
- Approval date
- Apr 28, 2020
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Guaifenesin and Pseudoephedrine Hydrochloride (Tablet, Extended Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| CVS Pharmacy | GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| CVS Pharmacy, Inc. | GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Publix Super Markets, Inc | GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Reckitt Benckiser LLC | GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Reckitt Benckiser LLC | GUAIFENESIN 1200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Rugby Laboratories, Inc. | GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Strategic Sourcing Services Llc | GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Walgreen Company | GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Walgreen Company | GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| A-S Medication Solutions | GUAIFENESIN 600 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 60 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Guaifenesin D — NDC 00363-9930-18," retrieved September 3, 2026, https://drugdashboards.com/drug/00363993018.
Free to cite with attribution — see how the data is put together.